Andy Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andy Ng has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
- David Juncker
McGill University
15 shared publications Mohammed Zourob
9 shared publications- Molly L. Shen
Biomedical Engineering Department, McGill University, Montreal, QC, Canada
6 shared publications Chiheb Esseghaier
5 shared publicationsFeng Ni
National Research Council
5 shared publications- Ghadeer A. R. Y. Suaifan
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan
4 shared publications
Latest Publications
- Open Access
Multiplexed visual test with readout synchronized to each respective clinical threshold for rogue anti-cytokine autoantibodies
Rapid tests with visual readout can quickly help identify and triage at-risk patients. However, multiplexed visual tests (MVTs) for targets with clinical thresholds above the limit of detection — e.g., rogue autoantibodies (raAbs) — are lacking because test interdependency and cross-reactivity make optimization intractable. Here, we introduce a conceptual and experimental framework to synchronize visual readout and clinical thresholds for multiple, cross-reacting targets simultaneously, and illustrate it with a 3D-printed, structurally-preprogrammed capillaric MVT for anti-interferon (IFN)-α and -ω raAbs and anti-SARS-CoV-2 spike protein (anti-SCoV2) antibodies. Using design of experiments, we sought and identified parameters that collectively govern the background of all tests (buffer composition, ionic strength), and ones that individually govern assay signal and sensitivity (capture probe density, sample volume), thus enabling both collective background reduction and independent tuning of test line visual threshold. The instrument-free MVT is highly sensitive (pg-ng mL −1 ), reproducible (CV<10% in plasma), and completed in <1 h. We benchmarked the threshold-calibrated MVTs to microplate ELISA with 41 COVID-19 patient plasma samples yielding ROC-AUCs of 0.97, 1.00, and 0.98 for anti-IFN-α, -IFN-ω, and -SCoV2 tests, respectively. The proposed framework for synchronizing multiple visual readouts with respective clinical thresholds, combined with capillarics, opens the door to instrumentation-free MVTs for point-of-care use.
Open AccessMultiplexed visual test with readout synchronized to each respective clinical threshold for rogue anti-cytokine autoantibodies
Rapid tests with visual readout can quickly help identify and triage at-risk patients. However, multiplexed visual tests (MVTs) for targets with clinical thresholds above the limit of detection — e.g., rogue autoantibodies (raAbs) — are lacking because test interdependency and cross-reactivity make optimization intractable. Here, we introduce a conceptual and experimental framework to synchronize visual readout and clinical thresholds for multiple, cross-reacting targets simultaneously, and illustrate it with a 3D-printed, structurally-preprogrammed capillaric MVT for anti-interferon (IFN)-α and -ω raAbs and anti-SARS-CoV-2 spike protein (anti-SCoV2) antibodies. Using design of experiments, we sought and identified parameters that collectively govern the background of all tests (buffer composition, ionic strength), and ones that individually govern assay signal and sensitivity (capture probe density, sample volume), thus enabling both collective background reduction and independent tuning of test line visual threshold. The instrument-free MVT is highly sensitive (pg-ng mL −1 ), reproducible (CV<10% in plasma), and completed in <1 h. We benchmarked the threshold-calibrated MVTs to microplate ELISA with 41 COVID-19 patient plasma samples yielding ROC-AUCs of 0.97, 1.00, and 0.98 for anti-IFN-α, -IFN-ω, and -SCoV2 tests, respectively. The proposed framework for synchronizing multiple visual readouts with respective clinical thresholds, combined with capillarics, opens the door to instrumentation-free MVTs for point-of-care use.
- Open Access
- 4 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Co-enrichment of proteins in extracellular vesicles
Extracellular vesicles are cell-derived secretions that mediate tissue homeostasis and intercellular communication through their diverse cargos, including proteins. Distinct extracellular vesicle biogenesis pathways suggest specific association and co-enrichment of proteins sharing a biogenesis pathway, and non-association and co-depletion of proteins segregated into distinct pathways. Yet these associations elude conventional protein expression or co-expression measurements. Here, we propose and define pairwise protein co-enrichment relative to its overall expression to quantify whether a given protein is co-enriched or co-depleted with another protein. We measure co-enrichment, and differential co-enrichment between a stimulus and a reference condition, of up to 240 protein pairs in extracellular vesicles using antibody microarrays. We validate co-enrichment by modulating well-known extracellular vesicle biogenesis pathways, and find that differential co-enrichment measures expected changes between perturbed and reference conditions. Co-enrichment and differential co-enrichment in three model cell lines and parental and organotropic breast cancer progeny cell lines reveal both preserved and variable co-enrichment that may warrant further studies. Collectively, our result suggest that co-enrichment reflects cell physiology and extracellular biogenesis, is readily measurable, and could serve as quality control in extracellular vesicle biomanufacturing.
- 4 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessCo-enrichment of proteins in extracellular vesicles
Extracellular vesicles are cell-derived secretions that mediate tissue homeostasis and intercellular communication through their diverse cargos, including proteins. Distinct extracellular vesicle biogenesis pathways suggest specific association and co-enrichment of proteins sharing a biogenesis pathway, and non-association and co-depletion of proteins segregated into distinct pathways. Yet these associations elude conventional protein expression or co-expression measurements. Here, we propose and define pairwise protein co-enrichment relative to its overall expression to quantify whether a given protein is co-enriched or co-depleted with another protein. We measure co-enrichment, and differential co-enrichment between a stimulus and a reference condition, of up to 240 protein pairs in extracellular vesicles using antibody microarrays. We validate co-enrichment by modulating well-known extracellular vesicle biogenesis pathways, and find that differential co-enrichment measures expected changes between perturbed and reference conditions. Co-enrichment and differential co-enrichment in three model cell lines and parental and organotropic breast cancer progeny cell lines reveal both preserved and variable co-enrichment that may warrant further studies. Collectively, our result suggest that co-enrichment reflects cell physiology and extracellular biogenesis, is readily measurable, and could serve as quality control in extracellular vesicle biomanufacturing.
- Open Access
- 7 November 2025
- Published by Springer Nature in Nature Methods
- Vol. 22 (11) , 2375-2385
nELISA: a high-throughput, high-plex platform enables quantitative profiling of the inflammatory secretome
Existing high-plex protein measurement tools compromise on quantification, precision and cost efficiency. Here, to address this, we present nELISA, a platform that combines a DNA-mediated, bead-based sandwich immunoassay with advanced multicolor bead barcoding. Antibody pairs are preassembled on target-specific, barcoded beads, which ensures spatial separation between noncognate assays. Detection antibodies are tethered via flexible single-stranded DNA to enable efficient ternary sandwich formation. Detection is achieved through toehold-mediated strand displacement, where fluorescently labeled DNA oligos simultaneously untether and label detection antibodies. nELISA delivers sub-picogram-per-milliliter sensitivity across seven orders of magnitude. Using a 191-plex inflammation panel, we profiled cytokine responses in 7,392 peripheral blood mononuclear cell samples, generating ~1.4 million protein measurements and revealing over 440 robust cytokine responses, including previously unreported effects. nELISA thus provides a simple, scalable and cost-efficient solution for large-scale, high-fidelity phenotypic screening.
- 7 November 2025
- Published by Springer Nature in Nature Methods
- Vol. 22 (11) , 2375-2385
Open AccessnELISA: a high-throughput, high-plex platform enables quantitative profiling of the inflammatory secretome
Existing high-plex protein measurement tools compromise on quantification, precision and cost efficiency. Here, to address this, we present nELISA, a platform that combines a DNA-mediated, bead-based sandwich immunoassay with advanced multicolor bead barcoding. Antibody pairs are preassembled on target-specific, barcoded beads, which ensures spatial separation between noncognate assays. Detection antibodies are tethered via flexible single-stranded DNA to enable efficient ternary sandwich formation. Detection is achieved through toehold-mediated strand displacement, where fluorescently labeled DNA oligos simultaneously untether and label detection antibodies. nELISA delivers sub-picogram-per-milliliter sensitivity across seven orders of magnitude. Using a 191-plex inflammation panel, we profiled cytokine responses in 7,392 peripheral blood mononuclear cell samples, generating ~1.4 million protein measurements and revealing over 440 robust cytokine responses, including previously unreported effects. nELISA thus provides a simple, scalable and cost-efficient solution for large-scale, high-fidelity phenotypic screening.
- Open Access
Microfluidic sieve and detector for rapid ultrasensitive assays with single-molecule sensitivity
The advent of ultrasensitive assays enabled many new research and clinical applications, but the time-to-result is hours and has not significantly improved over time, limiting their potential. We introduce the microfluidic sieve and detector (MFSD) that can sieve 200 microlitres in just one minute, and quantify captured analytes in four minutes, down to zeptomolar (10 -19 M) concentration. The MFSD comprises half a million 8-μm-diameter pores that bind analytes upon Brownian motion-induced wall collision. Conventional ensemble models and a stochastic Brownian agent dynamics introduced here reveal rapid, predictable and tuneable analyte capture under flow. Digital sandwich assays are completed by sequentially flowing the sample and reagents, partitioning the pores, and digitally revealing single ‘trapped’ analytes by enzymatic amplification. The MFSD tests are specific and reproducible, exhibit a large dynamic range, and are simple, tuneable and versatile, enabling measurement of different proteins including influenza A nucleoprotein in clinical samples, and even nucleic acids while being both faster and more sensitive than PCR. As such, the MFSD could open a new chapter for analysis and diagnostics.
Open AccessMicrofluidic sieve and detector for rapid ultrasensitive assays with single-molecule sensitivity
The advent of ultrasensitive assays enabled many new research and clinical applications, but the time-to-result is hours and has not significantly improved over time, limiting their potential. We introduce the microfluidic sieve and detector (MFSD) that can sieve 200 microlitres in just one minute, and quantify captured analytes in four minutes, down to zeptomolar (10 -19 M) concentration. The MFSD comprises half a million 8-μm-diameter pores that bind analytes upon Brownian motion-induced wall collision. Conventional ensemble models and a stochastic Brownian agent dynamics introduced here reveal rapid, predictable and tuneable analyte capture under flow. Digital sandwich assays are completed by sequentially flowing the sample and reagents, partitioning the pores, and digitally revealing single ‘trapped’ analytes by enzymatic amplification. The MFSD tests are specific and reproducible, exhibit a large dynamic range, and are simple, tuneable and versatile, enabling measurement of different proteins including influenza A nucleoprotein in clinical samples, and even nucleic acids while being both faster and more sensitive than PCR. As such, the MFSD could open a new chapter for analysis and diagnostics.
- Open Access
- 7 October 2025
- Published by Wiley in Advanced Materials
- Vol. 38 (13) , e06398
PiP‐Plex: A Particle‐in‐Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell's phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single‐cell level. Here we present PiP‐plex a particles‐in‐particle (PiPs) system for multiplex protein secretion analysis by confocal microscopy. PiP‐plex‐comprises (i) fluorescence intensity barcoded microparticles (BMPs) co‐entrapped with (ii) a single cell inside an alginate hydrogel particle. We found that PiPs maintained >90% cellular viability and allowed live cells retrieval. A seven‐plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs was developed with limits of detection ranging from 0.8 pg mL −1 to 2 ng mL −1 depending on the protein. PiP‐plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. Proteins secreted by single THP‐1 cells upon exposure to lipopolysaccharide were measured by PiP‐plex and varying cell responses detected, including a significant increase in MIP‐1α, TNF‐α, and IL‐17A; MIP‐1α and IL‐17A were the most frequently secreted cytokines, while other cytokines were typically co‐secreted. Using PiP‐plex, we analyzed ≈750 THP‐1 cells, showcasing its potential for characterizing cells and cell‐based therapeutics for e.g. cancer immunotherapies.
- 7 October 2025
- Published by Wiley in Advanced Materials
- Vol. 38 (13) , e06398
Open AccessPiP‐Plex: A Particle‐in‐Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell's phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single‐cell level. Here we present PiP‐plex a particles‐in‐particle (PiPs) system for multiplex protein secretion analysis by confocal microscopy. PiP‐plex‐comprises (i) fluorescence intensity barcoded microparticles (BMPs) co‐entrapped with (ii) a single cell inside an alginate hydrogel particle. We found that PiPs maintained >90% cellular viability and allowed live cells retrieval. A seven‐plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs was developed with limits of detection ranging from 0.8 pg mL −1 to 2 ng mL −1 depending on the protein. PiP‐plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. Proteins secreted by single THP‐1 cells upon exposure to lipopolysaccharide were measured by PiP‐plex and varying cell responses detected, including a significant increase in MIP‐1α, TNF‐α, and IL‐17A; MIP‐1α and IL‐17A were the most frequently secreted cytokines, while other cytokines were typically co‐secreted. Using PiP‐plex, we analyzed ≈750 THP‐1 cells, showcasing its potential for characterizing cells and cell‐based therapeutics for e.g. cancer immunotherapies.
- Open Access
PiP-plex: A Particle-in-Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell’s phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single cell level. Here, we present PiP-plex, a particles-in-particle (PiPs) system comprising (i) fluorescence intensity barcoded microparticles (BMPs) co-entrapped with (ii) a single cell inside an alginate hydrogel particle for multiplex protein secretion analysis by confocal microscopy. We show that developed PiPs maintained >90 % cellular viability and allowed live cells retrieval. A seven-plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs were implemented with limits of detection ranging from 0.8 pg mL -1 to 2 ng mL -1 depending on the protein. PiP-plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. We applied PiP-plex to analyze protein secreted by THP-1 cells upon exposure to lipopolysaccharide and detected varying cell responses, with a significant increase in MIP-1α, TNF-α and IL-17A. Multivariate analysis revealed that the majority of stimulated cells secreted either MIP-1α or IL-17A, while other cytokines were typically co-secreted. Using PiP-plex, we analyzed ∼750 THP-1 cells, showcasing its potential for characterizing cells and cell-based therapeutics for cancer immunotherapies.
Open AccessPiP-plex: A Particle-in-Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell’s phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single cell level. Here, we present PiP-plex, a particles-in-particle (PiPs) system comprising (i) fluorescence intensity barcoded microparticles (BMPs) co-entrapped with (ii) a single cell inside an alginate hydrogel particle for multiplex protein secretion analysis by confocal microscopy. We show that developed PiPs maintained >90 % cellular viability and allowed live cells retrieval. A seven-plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs were implemented with limits of detection ranging from 0.8 pg mL -1 to 2 ng mL -1 depending on the protein. PiP-plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. We applied PiP-plex to analyze protein secreted by THP-1 cells upon exposure to lipopolysaccharide and detected varying cell responses, with a significant increase in MIP-1α, TNF-α and IL-17A. Multivariate analysis revealed that the majority of stimulated cells secreted either MIP-1α or IL-17A, while other cytokines were typically co-secreted. Using PiP-plex, we analyzed ∼750 THP-1 cells, showcasing its potential for characterizing cells and cell-based therapeutics for cancer immunotherapies.
- Open Access
- 3 February 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-17
Gravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer
Background Circulating tumor cells (CTCs) are rare (a few cells per milliliter of blood) and mostly isolated as single-cell CTCs (scCTCs). CTC clusters (cCTCs), even rarer, are of growing interest, notably because of their higher metastatic potential, but very difficult to isolate. Method We introduce gravity-based microfiltration (GµF) for facile isolation of cCTCs using in-house fabricated microfilters and 3D printed cartridges. Optimal flow rate and pore size for cCTC isolation are determined by GµF of cultured ovarian single cells and cell clusters spiked in healthy blood. We perform GµF of blood from orthotopic ovarian cancer mouse models and characterize the morphological features of scCTCs and cCTCs, and the expression of molecular markers for aggressiveness. Finally, we analyze blood from 17 epithelial ovarian cancer patients with either localized or metastatic disease, and from 13 colorectal cancer liver metastasis patients. Results Here, we show that GµF optimized for cell cluster isolation captures cCTCs from blood while minimizing unwanted cluster disaggregation, with ~85% capture efficiency. We detect cCTCs in every patient, with between 2–100+ cells. We find cCTCs represent between 5–30% of all CTC capture events, and 10-80% of the CTCs are clustered; remarkably, in 10 patients, most CTCs are circulating not as scCTCs, but as cCTCs. Conclusions GµF uncovers the unexpected prevalence and frequency of cCTCs including sometimes very large ones in epithelial ovarian cancer patients, and motivates additional studies to uncover their properties and role in disease progression.
- 3 February 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-17
Open AccessGravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer
Background Circulating tumor cells (CTCs) are rare (a few cells per milliliter of blood) and mostly isolated as single-cell CTCs (scCTCs). CTC clusters (cCTCs), even rarer, are of growing interest, notably because of their higher metastatic potential, but very difficult to isolate. Method We introduce gravity-based microfiltration (GµF) for facile isolation of cCTCs using in-house fabricated microfilters and 3D printed cartridges. Optimal flow rate and pore size for cCTC isolation are determined by GµF of cultured ovarian single cells and cell clusters spiked in healthy blood. We perform GµF of blood from orthotopic ovarian cancer mouse models and characterize the morphological features of scCTCs and cCTCs, and the expression of molecular markers for aggressiveness. Finally, we analyze blood from 17 epithelial ovarian cancer patients with either localized or metastatic disease, and from 13 colorectal cancer liver metastasis patients. Results Here, we show that GµF optimized for cell cluster isolation captures cCTCs from blood while minimizing unwanted cluster disaggregation, with ~85% capture efficiency. We detect cCTCs in every patient, with between 2–100+ cells. We find cCTCs represent between 5–30% of all CTC capture events, and 10-80% of the CTCs are clustered; remarkably, in 10 patients, most CTCs are circulating not as scCTCs, but as cCTCs. Conclusions GµF uncovers the unexpected prevalence and frequency of cCTCs including sometimes very large ones in epithelial ovarian cancer patients, and motivates additional studies to uncover their properties and role in disease progression.
- Open Access
- 14 October 2024
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 13 (10) , e12512
Size photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity; however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label‐free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high‐throughput SPFI workflow recording >10,000 EVs in 7 min over ten 88 × 88 µm2 fields of view, pre‐ and post‐incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection and EV sizing. We achieve an EV sizing range from 37 to ∼220 nm in diameter with a dual 440 and 740 nm SP illumination scheme, and suggest that this range can be extended by more advanced image analysis or additional hardware customization. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label‐free sensitivity. We showcase SPFI's potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm‐in‐diameter EVs with fluorescently tagged membrane proteins.
- 14 October 2024
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 13 (10) , e12512
Open AccessSize photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity; however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label‐free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high‐throughput SPFI workflow recording >10,000 EVs in 7 min over ten 88 × 88 µm2 fields of view, pre‐ and post‐incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection and EV sizing. We achieve an EV sizing range from 37 to ∼220 nm in diameter with a dual 440 and 740 nm SP illumination scheme, and suggest that this range can be extended by more advanced image analysis or additional hardware customization. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label‐free sensitivity. We showcase SPFI's potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm‐in‐diameter EVs with fluorescently tagged membrane proteins.
- Open Access
Size photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity, however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label-free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high-throughput SPFI workflow recording >10,000 EVs in 7 min over multiple fields of view, pre- and post-incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection, and EV sizing. We identify the upper sizing limit of SP with 440 nm illumination and extend EVs sizing from ∼37 nm in diameter to >200 nm with dual 440 nm and 740 nm illumination. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label-free sensitivity. We showcase SPFI’s potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm-in-diameter EVs with fluorescently tagged membrane proteins.
Open AccessSize photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity, however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label-free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high-throughput SPFI workflow recording >10,000 EVs in 7 min over multiple fields of view, pre- and post-incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection, and EV sizing. We identify the upper sizing limit of SP with 440 nm illumination and extend EVs sizing from ∼37 nm in diameter to >200 nm with dual 440 nm and 740 nm illumination. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label-free sensitivity. We showcase SPFI’s potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm-in-diameter EVs with fluorescently tagged membrane proteins.
- Open Access
- 30 January 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (6) , 1547-1560
3D-printed capillaric ELISA-on-a-chip with aliquoting
Sandwich immunoassays such as the enzyme-linked immunosorbent assay (ELISA) have been miniaturized and performed in a lab-on-a-chip format, but the execution of the multiple assay steps typically requires a computer or complex peripherals. Recently, an ELISA for detecting antibodies was encoded structurally in a chip thanks to the microfluidic chain reaction (Yafia et al. Nature, 2022, 605, 464–469), but the need for precise pipetting and intolerance to commonly used surfactant concentrations limit the potential for broader adoption. Here, we introduce the ELISA-on-a-chip with aliquoting functionality that simplifies chip loading and pipetting, accommodates higher surfactant concentrations, includes barrier channels that delay the contact between solutions and prevent undesired mixing, and that executed a quantitative, high-sensitivity assay for the SARS-CoV-2 nucleocapsid protein in 4×-diluted saliva. Upon loading the chip using disposable pipettes, capillary flow draws each reagent and the sample into a separate volumetric measuring reservoir for detection antibody (70 μL), enzyme conjugate (50 μL), substrate (80 μL), and sample (210 μL), and splits washing buffer into 4 different reservoirs of 40, 40, 60, and 20 μL. The excess volume is autonomously drained via a structurally encoded capillaric aliquoting circuit, creating aliquots with an accuracy of >93%. Next, the user click-connects the assay module, comprising a nitrocellulose membrane with immobilized capture antibodies and a capillary pump, to the chip which triggers the step-by-step, timed flow of all aliquoted solutions to complete the assay in 1.5 h. A colored precipitate forming a line on a nitrocellulose strip serves as an assay readout, and upon digitization, yielded a binding curve with a limit of detection of 54 and 91 pg mL−1 for buffer and diluted saliva respectively, vastly outperforming rapid tests. The ELISA chip is 3D-printed, modular, adaptable to other targets and assays, and could be used to automate ELISA in the lab; or as a diagnostic test at the point of care with the convenience and form factor of rapid tests while preserving the protocol and performance of central laboratory ELISA.
- 30 January 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (6) , 1547-1560
Open Access3D-printed capillaric ELISA-on-a-chip with aliquoting
Sandwich immunoassays such as the enzyme-linked immunosorbent assay (ELISA) have been miniaturized and performed in a lab-on-a-chip format, but the execution of the multiple assay steps typically requires a computer or complex peripherals. Recently, an ELISA for detecting antibodies was encoded structurally in a chip thanks to the microfluidic chain reaction (Yafia et al. Nature, 2022, 605, 464–469), but the need for precise pipetting and intolerance to commonly used surfactant concentrations limit the potential for broader adoption. Here, we introduce the ELISA-on-a-chip with aliquoting functionality that simplifies chip loading and pipetting, accommodates higher surfactant concentrations, includes barrier channels that delay the contact between solutions and prevent undesired mixing, and that executed a quantitative, high-sensitivity assay for the SARS-CoV-2 nucleocapsid protein in 4×-diluted saliva. Upon loading the chip using disposable pipettes, capillary flow draws each reagent and the sample into a separate volumetric measuring reservoir for detection antibody (70 μL), enzyme conjugate (50 μL), substrate (80 μL), and sample (210 μL), and splits washing buffer into 4 different reservoirs of 40, 40, 60, and 20 μL. The excess volume is autonomously drained via a structurally encoded capillaric aliquoting circuit, creating aliquots with an accuracy of >93%. Next, the user click-connects the assay module, comprising a nitrocellulose membrane with immobilized capture antibodies and a capillary pump, to the chip which triggers the step-by-step, timed flow of all aliquoted solutions to complete the assay in 1.5 h. A colored precipitate forming a line on a nitrocellulose strip serves as an assay readout, and upon digitization, yielded a binding curve with a limit of detection of 54 and 91 pg mL−1 for buffer and diluted saliva respectively, vastly outperforming rapid tests. The ELISA chip is 3D-printed, modular, adaptable to other targets and assays, and could be used to automate ELISA in the lab; or as a diagnostic test at the point of care with the convenience and form factor of rapid tests while preserving the protocol and performance of central laboratory ELISA.